United Services Automobile Association acquired a new position in shares of Labcorp Holdings Inc. (NYSE:LH - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,604 shares of the medical research company's stock, valued at approximately $369,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LH. Golden State Wealth Management LLC lifted its stake in Labcorp by 88.1% in the first quarter. Golden State Wealth Management LLC now owns 111 shares of the medical research company's stock valued at $26,000 after buying an additional 52 shares during the last quarter. North Capital Inc. purchased a new stake in shares of Labcorp during the first quarter worth approximately $27,000. TruNorth Capital Management LLC acquired a new position in Labcorp during the first quarter worth $28,000. Larson Financial Group LLC grew its holdings in Labcorp by 140.4% during the first quarter. Larson Financial Group LLC now owns 125 shares of the medical research company's stock worth $29,000 after acquiring an additional 73 shares during the period. Finally, Financial Gravity Asset Management Inc. acquired a new stake in Labcorp in the first quarter valued at $31,000. Hedge funds and other institutional investors own 95.94% of the company's stock.
Wall Street Analyst Weigh In
LH has been the topic of several recent analyst reports. Morgan Stanley increased their target price on Labcorp from $283.00 to $306.00 and gave the stock an "overweight" rating in a research report on Friday, July 25th. Wall Street Zen upgraded Labcorp from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Truist Financial raised their price objective on Labcorp from $290.00 to $310.00 and gave the stock a "buy" rating in a report on Friday, July 25th. Evercore ISI raised their price objective on Labcorp from $285.00 to $300.00 and gave the company an "outperform" rating in a research note on Friday, July 25th. Finally, HSBC lowered Labcorp from a "buy" rating to a "hold" rating and set a $260.00 price objective for the company. in a research note on Thursday, July 10th. Nine equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $290.33.
Read Our Latest Stock Analysis on LH
Insider Transactions at Labcorp
In related news, CEO Adam H. Schechter sold 5,643 shares of the business's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $266.78, for a total transaction of $1,505,439.54. Following the transaction, the chief executive officer directly owned 93,319 shares in the company, valued at $24,895,642.82. The trade was a 5.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Der Vaart Sandra D. Van sold 3,903 shares of the company's stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $271.42, for a total value of $1,059,352.26. Following the completion of the sale, the executive vice president owned 2,274 shares in the company, valued at approximately $617,209.08. This represents a 63.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,546 shares of company stock worth $4,207,192 in the last ninety days. Company insiders own 0.84% of the company's stock.
Labcorp Stock Performance
Shares of NYSE LH traded down $0.70 during mid-day trading on Tuesday, hitting $274.71. The company had a trading volume of 124,437 shares, compared to its average volume of 689,859. The stock has a market cap of $22.83 billion, a price-to-earnings ratio of 30.32, a PEG ratio of 1.78 and a beta of 0.85. Labcorp Holdings Inc. has a 12 month low of $209.38 and a 12 month high of $283.47. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.50 and a quick ratio of 1.32. The firm's 50 day simple moving average is $266.21 and its two-hundred day simple moving average is $251.30.
Labcorp (NYSE:LH - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The medical research company reported $4.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.21. The business had revenue of $3.53 billion for the quarter, compared to the consensus estimate of $3.49 billion. Labcorp had a return on equity of 15.45% and a net margin of 5.66%.The business's revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $3.94 EPS. Labcorp has set its FY 2025 guidance at 16.050-16.500 EPS. As a group, equities research analysts forecast that Labcorp Holdings Inc. will post 16.01 earnings per share for the current year.
Labcorp Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 11th. Investors of record on Thursday, August 28th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $2.88 dividend on an annualized basis and a yield of 1.0%. Labcorp's dividend payout ratio (DPR) is presently 31.79%.
Labcorp Company Profile
(
Free Report)
Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Further Reading

Before you consider Labcorp, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Labcorp wasn't on the list.
While Labcorp currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.